Guardant Health
396 hedge funds and large institutions have $9.24B invested in Guardant Health in 2021 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 121 increasing their positions, 136 reducing their positions, and 54 closing their positions.
50% more call options, than puts
Call options by funds: $85.3M | Put options by funds: $56.7M
46% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 54
6% more funds holding
Funds holding: 374 → 396 (+22)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.99% less ownership
Funds ownership: 92.94% → 90.94% (-2%)
11% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 136
21% less capital invested
Capital invested by funds: $11.8B → $9.24B (-$2.53B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$273M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$108M |
| 3 |
SCM
Steadfast Capital Management
New York
|
+$104M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$84.6M |
| 5 |
CC
Casdin Capital
New York
|
+$81.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Coatue Management
New York
|
-$263M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$191M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$107M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$100M |
| 5 |
FAM
Fred Alger Management
New York
|
-$94.5M |
GH Hedge Fund Activity: Q4 2021 in Review
396 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2021, worth a combined $9.24B — down 21% from $11.8B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new GH positions and 54 closed out — a net gain of 25 holders — while 121 added to existing stakes and 136 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $273M. The largest seller was Coatue Management, cutting an estimated $263M.
- 396 institutional investors held Guardant Health (GH) as of Q4 2021, up from 374 in Q3 2021.
- Funds reported $9.24B of Guardant Health stock for Q4 2021, down 21% quarter-over-quarter.
- 79 funds opened new Guardant Health positions in Q4 2021 and 54 closed out, a net change of +25 holders.
- The largest Guardant Health buyer in Q4 2021 was Capital Research Global Investors, an estimated $273M added.
- The largest Guardant Health seller in Q4 2021 was Coatue Management, an estimated $263M sold.
Based on aggregated 13F filings for Q4 2021.